References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, American Psychiatric Association. 1994
   Google Scholar
• Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52(12): 1048–60.
   PubMed Web of Science ®Google Scholar
• Resnick HS, Kilpatrick DG, Dansky BS, Saunders BE, Best CL. Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol 1993; 61(6): 984–91.
   PubMed Web of Science ®Google Scholar
• Kulka RA, Schlenger WE, Fairbank JA, Hough RL, Jordan BK, Weiss DS. Trauma and the Vietnam War generation: report of findings from the National Vietnam Veterans Readjustment Study. New York, Brunner/Mazel. 1990
   Google Scholar
• Davidson J, Kudler H, Smith R, Mahorney SL, Lipper S, Hammett E, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 1990; 47(3): 259–66.
   PubMed Web of Science ®Google Scholar
• Frank JB, Kosten TR, Giller EL Jr, Dan E. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry 1988; 145(10): 1289–91.
   PubMed Web of Science ®Google Scholar
• Kosten TR, Frank JB, Dan E, McDougole CJ, Giller EL. Pharmacotherapy for posttraumatic stress disorder using phenalzine an imipramine. J Nerv Ment Dis 1991; 179(6): 366–70.
   PubMed Web of Science ®Google Scholar
• Reist C, Kauffmann CD, Haier RJ, Sangdahl C, DeMet EM, Chicz-DeMet A, et al. A controlled trial of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry 1989; 146(4): 513–6.
   PubMed Web of Science ®Google Scholar
• Shestatzky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res 1988; 24(2): 149–55.
   Web of Science ®Google Scholar
• van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994; 55(12): 517–22.
   PubMed Web of Science ®Google Scholar
• Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JR. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry 2000; 12(2): 101–5.
   Google Scholar
• Marmar CR, Schoenfeld F, Weiss DS, Metzler T, Zatzick D, Wu R, et al. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry Suppl 1996; 57(8): 66–70.
   Google Scholar
• Kline NA, Dow BM, Brown SA, Matloff JL. Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder. Am J Psychiatry 1994; 151(4): 621.
   Web of Science ®Google Scholar
• Shay J. Fluoxetine reduces explosiveness and elevates mood of Vietnam combat veterans with PTSD. J Trauma Stress 1992; 5(1): 97–101.
   Web of Science ®Google Scholar
• First MB, Gibbon M, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV (SCID-1). Washington: American Psychiatric Assosiation, 1997
   Google Scholar
• Çorapçıoğlu A, Aydemir Ö, Yıldız M, Esen E, Köroğlu E. DSM IV Eksen bozuklukları (SCID-1) için yapılandırılmış klinik görüşme, Klinik versiyon. Ankara: Hekimler Yayın Birliği; 1999
   Google Scholar
• Weathers FW, Keane TM, Davidson JRT. Clinician-Administered PTSD Scale: a review of the first ten years of research. Depress Anxiety 2001; 13(3): 132–56.
   PubMed Web of Science ®Google Scholar
• Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept of Health Education, and Welfare publication (ADM) 76–338. Rockville, Md: National Institute of Mental Health; 1976. p. 218–22.
   Google Scholar
• Aker AT, Özeren M, Başoğlu M, Kaptanoğlu C, Erol A, Buran B. Klinisyen tarafından uygulanan travma sonrası stres bozukluğu ölçeği (TSSB-Ö) geçerlik ve güvenilirlik çalışması. Türk Psikiyatri Dergisi—Turkish Journal of Psychiatry 1999; 10(4): 286–93.
   Google Scholar
• Beck AT, Steer RA. Manual for the Revised Beck Depression Inventory. San Antonio, Texas, Psychological Corp. 1987
   Google Scholar
• Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio, Texas, Psychological Corp. 1990
   Google Scholar
• Stein DJ, Ipser J, McAnda N. Pharmacotherapy of Posttraumatic Stress Disorder: A Review of Meta Analyses and Treatment Guidelines. CNS Spectr 2009; 14: 1(1): 25–31.
   Google Scholar
• Yorbık Ö, Dikkatli S, Cansever A, Söhmen T. The efficacy of fluoxetine treatment in children and adolescents with posttraumatic stress disorder symptoms. Klinik Psikofarmakoloji Bülteni—Bulletin of Clinical Psychopharmacology 2001; 11(4): 251–6.
   Google Scholar
• Zisook S, Chentsova-Dutton YE, Smith-Vaniz A, Kline NA, Ellenor GL, Kodsi AB, et al. Nefazodone in patients with treatment- refractory posttraumatic stress disorder. J Clin Psychiatry 2000; 61(3): 203–8.
   Web of Science ®Google Scholar
• Hidalgo R, Hertzberg MA, Mellman T, Petty F, Tucker P, Weisler R, et al. Nefazodone in posttraumatic stress disorder: results from six open-label trials. Int Clin Psychopharmacol 1999; 14(2): 61–8.
   Web of Science ®Google Scholar
• Doruk A, Yetkin S, Aydın H. The efficacy of sertraline on post-traumatic stress disorder. Klinik Psikofarmakoloji Bülteni—Bulletin of Clinical Psychopharmacology 1999; 9(1): 47–52.
   Google Scholar
• Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, et al. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technol Assess 2005; 9(16): 1–134.
   Web of Science ®Google Scholar
• Van der Kolk BA, Spinazzola J, Blaustein ME, Hopper JW, Hopper EK, Korn DL, et al. A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry 2007; 68(1): 37–46.
   PubMed Web of Science ®Google Scholar
• Penava SJ, Otto MW, Pollack MH, Rosenbaum JF. Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies. Depress Anxiety 1996–1997; 4(5): 240–2.
   Google Scholar
• Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Re, 2006; 1: CD002795,.
   Google Scholar
• Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol 2002; 22(2): 190–5.
   PubMed Web of Science ®Google Scholar
• Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder. J Clin Psychiatry 2006; 67(10): 1522–6.
   Web of Science ®Google Scholar
• Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry 2007; 68(5):711–20.
   PubMed Web of Science ®Google Scholar
• Kim Y, Asukai N, Konishi T, Kato H, Kato H, Hirotsune H, et al. Clinical evaluation of paroxetine in post-traumatic stress disorder (PTSD): 52-week, non-comparative open-label study for clinical use experience. Psychiatry Clin Neurosci 2008; 62(6): 646–52.
   Web of Science ®Google Scholar
• Marshall RD, Schneier FR, Fallon BA, Knight CB, Abbate LA, Goetz D, et al. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. J Clin Psychopharmacol 1998; 18(1): 10–8.
   PubMed Web of Science ®Google Scholar
• Davidson JR, Kudler HS, Saunders WB, Erickson L, Smith RD, Stein RM, et al. Predicting response to amitriptyline in posttraumatic stress disorder. Am J Psychiatry 1993; 150(7): 1024–9.
   PubMed Web of Science ®Google Scholar
• Ishii Y, Sumi T. Amitriptyline inhibits striatal efflux of neurotransmitters via blockade of voltage-dependent Na1 channels. Eur J Pharmacol 1992; 221(2–3): 377–80.
   Web of Science ®Google Scholar